Abstracts Archive - Page 1219 of 2425 - ACR Meeting Abstracts

Abstract Number: 201 • 2017 ACR/ARHP Annual Meeting
Computer Learning (artificial intelligence) to Create a Computer-Based Triage Tool Classifying Referrals As Inflammatory or Non-Inflammatory Requiring Only Patient Reported Information
Cindy Kim¹, Tanner Bohn², Charles X. Ling³, Nikhil Chopra⁴ and Janet E. Pope⁵, ¹Faculty of Medicine, University of Western Ontaro, London, ON, Canada, ²University of Western Ontario, London, ON, Canada, ³Computer Sciences, University of Western Ontario, London, ON, Canada, ⁴Rheumatology, Private Practice, London, ON, Canada, ⁵Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada
Background/Purpose: To determine if a computer-based triage tool can accurately classify referrals as inflammatory or non-inflammatory using information obtained from the patient; not requiring assessment…
Abstract Number: 202 • 2017 ACR/ARHP Annual Meeting
Analysis of Provider-to-Provider Variability in the Use of Biologics: Data from the Rheumatology Informatics System for Effectiveness Registry
Douglas White¹, Michael Evans², Gabriela Schmajuk³, Rachel Myslinski⁴, Salahuddin Kazi⁵ and Jinoos Yazdany⁶, ¹Gundersen Health System, Onalaska, WI, ²University of California San Francisco, San Francisco, CA, ³San Francisco VA Medical Center, University of California San Francisco, San Francisco, CA, ⁴Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA, ⁵University of Texas Southwestern, Dallas, TX, ⁶Medicine/Rheumatology, University of California San Francisco, San Francisco, CA
Background/Purpose: Variations in biologic prescribing habits by rheumatology providers may account in part for variability in direct cost of care for patients with rheumatoid arthritis…
Abstract Number: 203 • 2017 ACR/ARHP Annual Meeting
Intensive Care Unit Admissions Among Patients with Rheumatic Diseases at a Tertiary Care Center
Ali Al-Marzooq¹, Mohammed Al-Charakh¹, Sumediah Nzuonkwelle², Bikash Bhattarai³, Mark McPherson² and Konstantinos Parperis⁴, ¹Internal Medicine, Maricopa Integrated Health System, Phoenix, AZ, ²Maricopa Integrated Health System, Phoenix, AZ, ³Research, Maricopa Integrated Health System, phoenix, AZ, ⁴Rheumatology, Maricopa Integrated Health System and University of Arizona College of Medicine, Phoenix Campus, phoenix, AZ
Background/Purpose: Patients with autoimmune rheumatic diseases have higher risk of developing organ failure and may require admission to intensive care unit (ICU), however there are…
Abstract Number: 204 • 2017 ACR/ARHP Annual Meeting
Healthcare Utilization Among Young Adults Transitioning from Pediatric to Adult Care in a Safety Net Population
Nicole Bitencourt¹, Una E. Makris^1,2, Tracey Wright^3,4 and E. Blair Solow¹, ¹UT Southwestern Medical Center, Dallas, TX, ²Department of Medicine, VA North Texas Health Care System, Dallas, TX, ³Pediatrics/Rheumatology, UT Southwestern Medical Center, Dallas, TX, ⁴Texas Scottish Rite Hospital for Children, Dallas, TX
Background/Purpose: The transition from pediatric to adult care for young adults with chronic illness is a vulnerable period especially among socioeconomically disadvantaged populations. As part…
Abstract Number: 205 • 2017 ACR/ARHP Annual Meeting
What Is the Value of the Prior Authorization Process in Specialty Drug Therapy?
Shally Alendry¹, Melad Qodsi¹, Travis Hunerdossse¹ and Eric M. Ruderman^2,3, ¹Northwestern Medicine, Chicago, IL, ²Northwestern University Feinberg School of Medicine, Chicago, IL, ³Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: As the use of specialty pharmacy drugs has grown, many insurers have instituted strict prior authorization requirements, ostensibly to ensure that the right patients…
Abstract Number: 206 • 2017 ACR/ARHP Annual Meeting
Real World IGRA Testing in Rheumatology Practice
Paul DeMarco^1,2, Megan Bishop³, Ashling Smith⁴, Herbert S. B. Baraf^1,5, Andrew Gregory DeMarco⁶, Temitope Ademola⁷, Deborah Contreras⁸, Adalisa Enriquez RMA¹, Lisa Klein¹, Kayra Perez¹, Sandra Ventura¹, Janice Whyte-Whitworth¹, Vince Calhoun¹, Theresa Bass Goldman¹ and Alan K Matsumoto^1,9, ¹The Center for Rheumatology and Bone Research, Wheaton, MD, ²Division of Rheumatology, Department of Medicine, Georgetown University School of Medicine, Washington, DC, ³Clinical Trials, The Center for Rheumatology and Bone Research, Wheaton, MD, ⁴2730 University Blvd West, Suite 306, The Center for Rheumatology and Bone Research, Wheaton, MD, ⁵Department of Medicine, George Washington University School of Medicine, Washington, DC, ⁶Department of Biochemistry and Molecular Cellular Biology, Georgetown University Department of Biochemistry and Molecular Cellular Biology, Washington, DC, ⁷The Center for Rheumatology and Bone Research, Washington, DC, ⁸2730 University Boulevard West, Suite 306, The Center for Rheumatology and Bone Research, Wheaton, MD, ⁹Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD
Background/Purpose: Mycobacterium tuberculosis (MTb) screening is routine for clinical trial protocols, & authorization for immunomodulators use by health insurances. Real world data is needed to…
Abstract Number: 207 • 2017 ACR/ARHP Annual Meeting
Direct Medical Costs of Systemic Lupus Erythematosus in South Korea
So-Yeon Park¹ and Sang-Cheol Bae², ¹Department of Rhematology, Myongji Hospital, Seonam university, Goyang, Korea, Republic of (South), ²Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South)
Background/Purpose: Systemic lupus erythematosus (SLE) has very high economic burdens on society and healthcare system. The aim of this study was to estimate the annual…
Abstract Number: 208 • 2017 ACR/ARHP Annual Meeting
Influence of Depression on Healthcare Expenditures Among Adults with Spondylosis, Intervertebral Disc Disorders and Other Back Problems in the United States
Jawad Bilal¹, Adam Berlinberg¹, Jaren Trost¹, Sandipan Bhattacharjee² and Irbaz Bin Riaz¹, ¹Banner University Medical Center, Tucson, AZ, ²Department of Pharmacy, University of Arizona, Tucson, AZ
Background/Purpose: Back pain is a very prevalent complaint affecting two-thirds of population, and accounts for 90.7 billion dollars annually in healthcare expenditure. The occurrence of…
Abstract Number: 209 • 2017 ACR/ARHP Annual Meeting
Epidemiologic Subsets Drive a Differentiated Thoracic and Extrathoracic Presentation of Sarcoidosis: Analysis of 1082 Patients from the Sarcogeas-SEMI Registry
Soledad Retamozo^1,2,3, Roberto Pérez-Alvarez⁴, Guadalupe Fraile⁵, Ricardo Gómez De La Torre⁶, Miguel López Dupla⁷, Begoña De Escalante Yangüela⁸, Ana Alguacil⁹, Joel Chara-Cervantes¹⁰, Jose Velilla Marco¹⁰, Francisco Javier Rascón¹¹, Jose Salvador Garcia Morillo¹², Carles Tolosa¹³, Eva Fonseca Aizpuru¹⁴, Mariona Bonet¹⁵, José Luis Callejas¹⁶, Gloria De la Red¹⁷, Eva Calvo Begueria¹⁸, Cristina Soler i Ferrer¹⁹, Enrique Peral Gutiérrez De Ceballos²⁰, Jorge Francisco Gómez Cerezo²¹, Gracia Cruz Caparrós²², Patricia Perez Guerrero²³, Sergio Rodríguez Fernández²⁴, Blanca Pinilla²⁵, Alberto Gato Diez²⁶, Miriam Akasbi²⁷, Angel Robles²⁸, Inmaculada Ojeda²⁹, Maria José Vives³⁰, César Morcillo³¹, María Penadés Vidal³², Moisés De Vicente³³, Belchin Kostov³⁴, Manuel Ramos-Casals³⁵, Lucio Pallarés¹¹ and Pilar Brito-Zerón², ¹Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Cordoba, Argentina, ²Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, ³Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, ⁴Department of Internal Medicine, Hospital Alvaro Cunqueiro, Vigo, Vigo, Spain, ⁵Autoimmune Diseases Department, Hospital Ramón y Cajal, Madrid, Spain, ⁶Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Oviedo, Spain, ⁷Department of Internal Medicine, Hospital Universitari Joan XXIII, Tarragona, Tarragona, Spain, ⁸Department of Internal Medicine, Hospital Clínico, Zaragoza, Zaragoza, Spain, ⁹Department of Internal Medicine, Hospital Virgen de la Salud, Toledo, Toledo, Spain, ¹⁰Hospital Universitario Miguel Servet, Zaragoza, Zaragoza, Spain, ¹¹Department of Internal Medicine, Hospital Son Espases. Palma de Mallorca, Palma de Mallorca, Spain, ¹²Department of Internal Medicine, Hospital Virgen del Rocio, Sevilla, Sevilla, Spain, ¹³Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Barcelona, Spain, ¹⁴Department of Internal Medicine, Hospital de Cabueñes, Gijón, Gijón, Spain, ¹⁵Department of Internal Medicine, Althaia, Xarxa Assistencial de Manresa, Manresa, Spain, ¹⁶Department of Internal Medicine, Hospital Clínico San Cecilio, Granada, Granada, Spain, ¹⁷Department of Internal Medicine, Hospital Esperit Sant, Badalona, Badalona, Spain, ¹⁸Hospital General San Jorge, Huesca, Huesca, Spain, ¹⁹Department of Internal Medicine, Hospital de Santa Caterina, Girona, Girona, Spain, ²⁰Department of Internal Medicine, Hospital Virgen Macarena, Sevilla, Sevilla, Spain, ²¹Department of Internal Medicine, Hospital Infanta Sofía, San Sebastián, San Sebastian, Spain, ²²Department of Internal Medicine, Hospital de Poniente El Ejido, Almería, Almería, Spain, ²³Department of Internal Medicine, Hospital Universitario Puerta del Mar, Cádiz, Cadiz, Spain, ²⁴Department of Internal Medicine, Hospital da Barbanza, A Coruña, A Coruña, Spain, ²⁵Department of Internal Medicine, Hospital Gregorio Marañón, Madrid, Madrid, Spain, ²⁶Department of Internal Medicine, Complejo Hospitalario Albacete, Albacete, Albacete, Spain, ²⁷Department of Internal Medicine, Hospital Infanta Leonor, Madrid, Madrid, Spain, ²⁸Internal Medicine, Hospital La Paz, Madrid, Spain, ²⁹Department of Internal Medicine, Hospital Valle del Guadiato, Córdoba, Cordoba, Spain, ³⁰Department of Internal Medicine, Parc Sanitari San Joan de Déu, San Boi de Llobregat, Barcelona, Spain, ³¹Department of Medicine, Hospital CIMA-Sanitas, Barcelona, Barcelona, Spain, ³²Department of Internal Medicine, Hospital De Manises, Valencia, Valencia, Spain, ³³Department of Internal Medicine, Hospital Nuestra Señora del Prado, Talavera, Talavera, Spain, ³⁴Primary Care Research Group, IDIBAPS, Centre d’Assistència Primària ABS Les Corts, CAPSE, Barcelona, Barcelona, Spain, ³⁵Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain, Barcelona, Spain
Background/Purpose: To analyse whether epidemiologic factors (such as gender or age at diagnosis of the disease) are associated with particular disease expressions and define specific…
Abstract Number: 210 • 2017 ACR/ARHP Annual Meeting
Pharmacovigilance Surveillance of Autoimmune Diseases Induced By Biological Agents: A Review of 12013 Cases (aeBIOGEAS-SEMI Registry)
Soledad Retamozo^1,2,3, Manuel Ramos-Casals^4,5, Marta Pérez de Lis⁶, Alejandra Flores-Chavez^7,8,9, Sofia Arteaga^10,11, Celeste Galcerán-Chaves¹², Belchin Kostov¹³, Roberto Pérez-Alvarez⁶ and Pilar Brito-Zerón^2,14, ¹Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Cordoba, Argentina, ²Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, ³Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, ⁴Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain, Barcelona, Spain, ⁵Department of Medicine, University of Barcelona, Barcelona, Spain., Barcelona, Spain, ⁶Department of Internal Medicine, Hospital Alvaro Cunqueiro, Vigo, Vigo, Spain, ⁷Department of Autoimmune Diseases, ICMiD, Hospital Clínic Barcelona, Spain., Barcelona, Spain, ⁸Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, ⁹Programa de Doctorado en Ciencias Médicas, Centro Universitario de Investigaciones Biomédicas (CUIB), Universidad de Colima, Colima, Mexico, Mexico, Mexico, ¹⁰Residente de Reumatologia II año, Universidad de Antioquia, Medellin, Colombia, Medellin, Colombia, ¹¹d) Department of Autoimmune Diseases, ICMiD, Hospital Clínic Barcelona, Spain., Barcelona, Spain, ¹²Neuroscience Clinical Institute, Hospital Clínic, Barcelona, Spain, Barcelona, Spain, ¹³Primary Care Research Group, IDIBAPS, Centre d’Assistència Primària ABS Les Corts, CAPSE, Barcelona, Barcelona, Spain, ¹⁴Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona., Bacelona, Spain
Background/Purpose: The increasing use of biological agents has been linked with the paradoxical development of autoimmune processes. The scenario has dramatically change in recent years…
Abstract Number: 211 • 2017 ACR/ARHP Annual Meeting
Hopes and Fears of Patients with Axial Spondyloarthritis in Spain. the Value of Patient Opinion: Results from the Spanish Atlas
Marco Garrido-Cumbrera¹, Pedro Plazuelo-Ramos², Olta Brace¹, David Galvez-Ruiz¹ and Jorge Chacon-Garcia¹, ¹Universidad de Sevilla, Seville, Spain, ²CEADE, Madrid, Spain
Background/Purpose: Not much attention has been paid to listening to the opinions of patients in most scientific studies on Spondyloarthritis, despite their opinions playing an…
Abstract Number: 212 • 2017 ACR/ARHP Annual Meeting
Treatment Patterns in Large Vessel Arteritis (Giant Cell Arteritis and Temporal Arteritis): Findings from a Large Contemporaneous Real-World Cohort in the US
Zhaohui Su¹, Vandana Menon¹, Richard Gliklich² and Tom Brecht¹, ¹Research, OM1, Inc, Cambridge, MA, ²OM1, Inc, Cambridge, MA
Background/Purpose: Giant cell arteritis (GCA) is the most common form of primary systemic vasculitis with annual incidence as high as 27 per 100,000 in persons…
Abstract Number: 213 • 2017 ACR/ARHP Annual Meeting
Perception of Access to Mental Health Services in Publicly Insured Vs Privately Insured Patients with Rheumatic Diseases
Elizabeth Soto-Cardona, Jackie Szymonifka and Robert F. Spiera, Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: To assess perception of access to mental health services (MHS) and utilization of those services based on participant’s insurance type. We compared responses of…
Abstract Number: 214 • 2017 ACR/ARHP Annual Meeting
Ambulatory and Hospital Care for Arthritis and Related Conditions in Ontario, Canada
Y. Raja Rampersaud¹, J. Denise Power², Anthony V. Perruccio², Michael Paterson³, Christian Veillette², Elizabeth M. Badley⁴ and Nizar Mahomed², ¹Arthritis Program, Krembil Research Institute, University Health Network, Torotno, ON, Canada, ²Arthritis Program, Krembil Research Institute, University Health Network, Toronto, ON, Canada, ³Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁴Health Care & Outcomes Research, Krembil Research Institute, University Health Network, Toronto, ON, Canada
Background/Purpose: Ontario, Canada’s most populous province, has publicly funded, universal health insurance covering medically necessary hospital and physician services with no copayments. The purpose of…
Abstract Number: 215 • 2017 ACR/ARHP Annual Meeting
Clinical Pharmacist As Part of the Interprofessional Team Improves Quality of Care in Patients with Rheumatic Disease
Jessica Farrell¹, Lee S. Shapiro¹ and Mitchell Miller², ¹The Center for Rheumatology, Albany, NY, ²Albany College of Pharmacy and Health Sciences, Albany, NY
Background/Purpose: Successful multidisciplinary models exist for the management of chronic diseases such as diabetes, cardiovascular disease, infectious diseases, kidney disease and psychiatric illnesses. A multidisciplinary…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].